HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satya Yendluri Selected Research

Atherosclerosis

2/2015Development of lipoprotein(a) siRNAs for mechanism of action studies in non-human primate models of atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satya Yendluri Research Topics

Disease

3Neoplasms (Cancer)
04/2009 - 05/2006
2Glioblastoma (Glioblastoma Multiforme)
08/2006 - 05/2006
1Staphylococcal Infections
01/2021
1Dyslipidemias (Dyslipidemia)
12/2016
1Mitochondrial Diseases (Mitochondrial Disease)
12/2016
1Atherosclerosis
02/2015
1Coronary Disease (Coronary Heart Disease)
02/2015
1Disease Progression
05/2006

Drug/Important Bio-Agent (IBA)

2Small Interfering RNA (siRNA)IBA
12/2016 - 02/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2006 - 05/2006
1FluoroquinolonesIBA
01/2021
1Moxifloxacin (Avelox)FDA Link
01/2021
1NucleotidesIBA
12/2016
1Proteins (Proteins, Gene)FDA Link
12/2016
1oxidized low density lipoproteinIBA
12/2016
1SREBP cleavage-activating proteinIBA
12/2016
1LipidsIBA
12/2016
1Lipoprotein(a)IBA
02/2015
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2009
1Capsid Proteins (Capsid Protein)IBA
08/2006
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
05/2006
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
05/2006
1Pharmaceutical PreparationsIBA
05/2006